Aztreonam now available for inhalation

Gilead Science has launched Cayston powder and solvent for nebuliser solution.

It is the first nebulised formulation of aztreonam for the suppressive therapy of chronic pulmonary infections due to Pseudomonas aeruginosa in cystic fibrosis.

Cayston should only be used with the Altera Nebuliser Handset and Altera Aerosol Head connected to an Altera Control Unit or an eFlow rapid Control unit.

View Cayston drug record

Further information: Gilead

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in